Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-19

Clinical Trial Update: Ureter Identification With IRDye 800BK [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on using IRDye 800BK for ureter identification; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRDye 800BK

Snippet

Sponsor: Oxford University Hospitals NHS Trust | Conditions: Ureter Injury | Phase 1, Phase 2 | Status: COMPLETED